Genetic analysis specifically detected the KRAS G12V mutation and tumor cells were partially positive for p53 in the ovarian tumor, although examinations for PTPRK and DICER1 gene mutations were not performed. This evidence concerns the gene TP53 and ovarian neoplasm.